Product Images Myalept
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 82 images provide visual information about the product associated with Myalept NDC 10122-210 by Chiesi Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a vial with liquid intended for mixing medicine, along with a syringe for mixing the medicine. The syringe includes a plunger, a longer needle, and a needle cover.*
This text provides a list of items related to medication administration, including a vial with powder, cap, syringe for injecting medicine (with a suggested volume of 1.0 mL or smaller), alcohol wipes, insulin syringe, container stickers for noting the last day the mixed medicine can be used, a pen for writing, and instructions to discard the vial after dosing. Additionally, the insulin syringe is marked in units with a shorter needle and cover. It also includes a diagram labeled as "Figure A."*
This text provides information about the quantities of liquid in different containers: one container contains 1 milliliter (mL) per short line, another container contains 20 mL, and a third container contains 22 mL.*
This text explains how to measure doses using a syringe by aligning the plunger with the unit lines for the prescribed dose. Short lines represent 0.01 mL, medium lines are 0.05 mL, and long lines count up by 0.1 mL. The example features a Tuberculin Syringe showing how to measure doses.*
Description: myalept® is a medication for injection containing 3 mg per vial of metreleptin, intended for subcutaneous use. The single-dose vial can be reconstituted with Water for Injection, while the multi-dose vial with Bacteriostatic Water for Injection. It is recommended to store myalept® refrigerated at 36°F to 46°F (2°C to 5°C). Produced by Chiesi Farmaceutici S.p.A., Parma, Italy. The National Drug Code (NDC) is 10122-210-01.*
This description is about Myalept® (metreleptin) injection, manufactured in Italy by Chiesi Farmaceutici S.p.A. The vial contains 11.3 mg of metreleptin, to deliver 5 mg per mL when reconstituted. It includes instructions for storage, reconstitution, and usage, emphasizing subcutaneous use only. The solution after reconstitution contains various components like glutamic acid and glycine. It mentions the importance of following healthcare provider instructions, providing a website and helpline for more information. The text warns that the package is not child-resistant and should be kept out of reach of children.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.